Drug Discovery · Cambridge, MA · Founded 2024 · Privately Held (backing)
Operator of a biotechnology company intended to develop innovative, precise, and effective treatments for a wide range of diseases. City Therapeutics is based in Cambridge, MA and was founded in 2024. It is valued at about $285 million as of Oct 2026, set by institutional fund marks. It has raised $140 million across 1 recorded round; the latest was a $135 million Series A in Oct 2024.
PMV mark · valuation
$285.5M
Oct 2026
Priced at
its Series A
Oct 2024
Total raised
$139.5M
Last round
Early Stage VC (Series A)
Oct 2024
Team — not yet on record
No current team members for City Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of City Therapeutics with a free account
·Watch City Therapeutics: the Monday email on marks, rounds and moves
